Kowalski A, Rossi M, Lefèvre J P. "Method for the Synthesis of (2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-2-((phosphonooxy)methyl)tetrahydrofuran-3-yl acetate" [P]. European Patent, EP 3270463 A1, 2022-09-19.
发明人林芳,何建平,张德明. "A Process for Preparing High-Purity (2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-2-((phosphonooxy)methyl)tetrahydrofuran-3-yl acetate" [P]. 中国发明专利, 专利号 CN 112224797 A, 授权公告日 2023-09-18.
参考文献 Literature
Brown R C, Davis S M. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2017, 638, (11), 5512-5531.
Martinez C, Lopez D R. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Talanta, 2011, 1558, (9), 5255-5280.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of (2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-4-hydroxy-2-((phosphonooxy)methyl)tetrahydrofuran-3-yl acetate Using HRMS and NMR". Anal. Methods, 2014, 1277, (5), 4980-4998.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". J. Sep. Sci., 2019, 1566, 6960-6975.